Acute lymphoblastic leukemia overview

Revision as of 14:28, 27 August 2015 by Carlos Lopez (talk | contribs)
Jump to navigation Jump to search

Acute lymphoblastic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Acute lymphoblastic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Bone X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute lymphoblastic leukemia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute lymphoblastic leukemia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute lymphoblastic leukemia overview

CDC on Acute lymphoblastic leukemia overview

Acute lymphoblastic leukemia overview in the news

Blogs on Acute lymphoblastic leukemia overview

Directions to Hospitals Treating Acute lymphoblastic leukemia

Risk calculators and risk factors for Acute lymphoblastic leukemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Acute lymphoblastic leukemia is a form of leukemia, or cancer of the white blood cells. Acute refers to the undifferentiated, immature state of the circulating lymphocytes ("blasts") and to the rapid progression of disease, which can be fatal in weeks to months if left untreated.

The classification subtyping of the various forms of Acute limphocytic leukemia used to be done according to the French-American-British (FAB) classification which was used for all Acute leukemias (including acute myelogenous leukemia (AML)). As Acute lymphocytic leukemia is not a solid tumour, the TxNxMx notation as used in solid cancers only. The recent World Health Organization International panel on Acute lymphoblastic leukemia recommends that this classification be abandoned, since the morphological classification has no clinical or prognostic relevance. But here you can find both classifications for academic and historic porpouses.

The cause of most Acute lympoblastic leukemias is not known. In leukemias, including Acute lymphoblastic leukemia chromosomal translocations occurs regularly and can trigger oncogenes. Some families have a hereditary predisposition. Acute lymphoblastic leukemia is associated with exposure to radiation in animals and humans. Malignant, immature white blood cells continuously multiply and are overproduced in the bone marrow. There are specific markers for B-cell Acute lymphoblastic leukemia and T-cell Acute lymphoblastic leukemia.

Diagnostic confusion with Acute myelogenous leukemia, hairy cell leukemia, and malignant lymphoma is not uncommon. Proper diagnosis is crucial because of the difference in prognosis and treatment of Acute Lymphoblastic leukemia and Acute Myelogenous leukemia.


References

Template:WH Template:WS